4.8 Article

Baricitinib protects mice from sepsis-induced cardiac dysfunction and multiple-organ failure

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Surgery

Inhibition of Bruton's Tyrosine Kinase Activity Attenuates Hemorrhagic Shock-Induced Multiple Organ Dysfunction in Rats

Nikita M. Patel et al.

Summary: The aim of this study was to investigate the potential of BTK inhibitors acalabrutinib and fenebrutinib in reducing MODS in acute hemorrhagic shock rat models and to determine their effects on BTK, NF-kappa B, and NLRP3 activation in HS. The results showed that treatment with either acalabrutinib or fenebrutinib attenuated organ injury and dysfunction in acute HS models and reduced the activation of BTK, NF-kappa B, and NLRP3 pathways in the kidney. These findings suggest that BTK inhibitors may be a potential therapeutic approach for MODS after trauma and/or hemorrhage.

ANNALS OF SURGERY (2023)

Article Surgery

Inhibition of the JAK/STAT Pathway With Baricitinib Reduces the Multiple Organ Dysfunction Caused by Hemorrhagic Shock in Rats

Nikita M. Patel et al.

Summary: The study aimed to investigate the effects of the JAK/STAT pathway inhibitor (baricitinib) on MODS in a rat model of HS and whether it attenuates the activation of JAK/STAT, NF-kappa B, and NLRP3 caused by HS. The results showed that baricitinib treatment during resuscitation following severe hemorrhage attenuated organ injury and dysfunction, as well as the activation of JAK/STAT, NF-kappa B, and NLRP3 pathways. These findings suggest that JAK inhibitors may have potential for treating MODS after trauma and/or hemorrhage.

ANNALS OF SURGERY (2023)

Article Critical Care Medicine

Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation: an exploratory, randomised, placebo-controlled trial

E. Wesley Ely et al.

Summary: This study evaluated the efficacy and safety of baricitinib plus standard of care in critically ill COVID-19 patients. The results showed that compared to placebo, treatment with baricitinib significantly reduced mortality at both 28 and 60 days. Additionally, there were no significant differences in ventilator-free days and hospitalization duration between the baricitinib and placebo groups.

LANCET RESPIRATORY MEDICINE (2022)

Article Surgery

Resolvin D1 Attenuates the Organ Injury Associated With Experimental Hemorrhagic Shock

Regina Sordi et al.

Summary: The study found that trauma results in a significant reduction in plasma levels of resolvin D1 in patients. In rat experiments, RvD1 has a protective effect on organ damage and dysfunction caused by hemorrhagic shock.

ANNALS OF SURGERY (2021)

Article Critical Care Medicine

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo- controlled phase 3 trial

Vincent C. Marconi et al.

Summary: Although there was no significant reduction in the frequency of disease progression overall, treatment with baricitinib in addition to standard of care (including dexamethasone) had a similar safety profile to that of standard care alone, and was associated with reduced mortality in hospitalised adults with COVID-19.

LANCET RESPIRATORY MEDICINE (2021)

Review Immunology

Inflammasomes: Pandora's box for sepsis

Vijay Kumar

JOURNAL OF INFLAMMATION RESEARCH (2018)

Article Urology & Nephrology

IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD

Jianmin Chen et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Article Medicine, General & Internal

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

Mervyn Singer et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Review Medicine, General & Internal

Pathophysiology of sepsis-induced myocardial dysfunction

Xiuxiu Lv et al.

MILITARY MEDICAL RESEARCH (2016)

Article Cardiac & Cardiovascular Systems

Left Ventricular Systolic Longitudinal Function as Predictor of Outcome in Patients With Sepsis

Vittorio Palmieri et al.

CIRCULATION-CARDIOVASCULAR IMAGING (2015)

Article Critical Care Medicine

Myocardial depression in sepsis: From pathogenesis to clinical manifestations and treatment

Elio Antonucci et al.

JOURNAL OF CRITICAL CARE (2014)

Editorial Material Orthopedics

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

C. Kilkenny et al.

OSTEOARTHRITIS AND CARTILAGE (2012)

Article Multidisciplinary Sciences

Cecal Ligation Puncture Procedure

Miguel G. Toscano et al.

JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)

Review Cardiac & Cardiovascular Systems

Sepsis and the heart

M. W. Merx et al.

CIRCULATION (2007)

Article Critical Care Medicine

The effect of age on the development and outcome of adult sepsis

GS Martin et al.

CRITICAL CARE MEDICINE (2006)